{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T03:48:04Z","timestamp":1773028084053,"version":"3.50.1"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1016\/j.juro.2009.05.011","type":"journal-article","created":{"date-parts":[[2009,7,18]],"date-time":"2009-07-18T09:02:15Z","timestamp":1247907735000},"page":"900-906","source":"Crossref","is-referenced-by-count":179,"title":["Adjuvant Chemotherapy for High Risk Upper Tract Urothelial Carcinoma: Results From the Upper Tract Urothelial Carcinoma Collaboration"],"prefix":"10.1097","volume":"182","author":[{"given":"Nicholas J.","family":"Hellenthal","sequence":"first","affiliation":[{"name":"University of California-Davis, Sacramento, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahrokh F.","family":"Shariat","sequence":"additional","affiliation":[{"name":"University of Texas Southwestern, Dallas, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vitaly","family":"Margulis","sequence":"additional","affiliation":[{"name":"University of Texas M. D. Anderson Cancer Center, Houston, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre I.","family":"Karakiewicz","sequence":"additional","affiliation":[{"name":"University of Montreal, Montreal, Quebec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Roscigno","sequence":"additional","affiliation":[{"name":"University of Vienna, Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Bolenz","sequence":"additional","affiliation":[{"name":"University of Texas Southwestern, Dallas, Texas"},{"name":"Universitatsklinikum Mannheim, Mannheim, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mesut","family":"Remzi","sequence":"additional","affiliation":[{"name":"Vita-Salute University, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alon","family":"Weizer","sequence":"additional","affiliation":[{"name":"University of Michigan, Ann Arbor, Michigan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Zigeuner","sequence":"additional","affiliation":[{"name":"Medical University Graz, Graz, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karim","family":"Bensalah","sequence":"additional","affiliation":[{"name":"University of Rennes, Rennes, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Casey K.","family":"Ng","sequence":"additional","affiliation":[{"name":"Cornell University, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay D.","family":"Raman","sequence":"additional","affiliation":[{"name":"Cornell University, New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiji","family":"Kikuchi","sequence":"additional","affiliation":[{"name":"Keio University School of Medicine, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Montorsi","sequence":"additional","affiliation":[{"name":"Vita-Salute University, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mototsugu","family":"Oya","sequence":"additional","affiliation":[{"name":"Keio University School of Medicine, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher G.","family":"Wood","sequence":"additional","affiliation":[{"name":"University of Texas M. D. Anderson Cancer Center, Houston, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Fernandez","sequence":"additional","affiliation":[{"name":"Clinica Alemana de Santiago, Santiago de Chile, Chile"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher P.","family":"Evans","sequence":"additional","affiliation":[{"name":"University of California-Davis, Sacramento, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theresa M.","family":"Koppie","sequence":"additional","affiliation":[{"name":"University of California-Davis, Sacramento, California"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2009.05.011_bib1","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/ncpuro0875","article-title":"Management of patients with upper urinary tract transitional cell carcinoma","volume":"4","author":"Raman","year":"2007","journal-title":"Nat Clin Pract Urol"},{"key":"10.1016\/j.juro.2009.05.011_bib2","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S0090-4295(98)00295-7","article-title":"Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients","volume":"52","author":"Hall","year":"1998","journal-title":"Urology"},{"key":"10.1016\/j.juro.2009.05.011_bib3","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1002\/1097-0142(19891215)64:12<2448::AID-CNCR2820641209>3.0.CO;2-7","article-title":"Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium","volume":"64","author":"Sternberg","year":"1989","journal-title":"Cancer"},{"key":"10.1016\/j.juro.2009.05.011_bib4","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1056\/NEJMoa022148","article-title":"Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer","volume":"349","author":"Grossman","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.juro.2009.05.011_bib5","doi-asserted-by":"crossref","first-page":"4963","DOI":"10.1200\/JCO.2005.11.094","article-title":"Adjuvant cisplatin plus methotrexate versus methotrexate, vinblastine, epirubicin, and cisplatin in locally advanced bladder cancer: results of a randomized, multicenter, phase III trial (AUO-AB 05\/95)","volume":"23","author":"Lehmann","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.juro.2009.05.011_bib6","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0022-5347(17)38733-5","article-title":"M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) chemotherapy for transitional cell carcinoma: the Princess Margaret Hospital experience","volume":"142","author":"Tannock","year":"1989","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2009.05.011_bib7","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1002\/1097-0142(19881101)62:9<2016::AID-CNCR2820620924>3.0.CO;2-G","article-title":"Tumor grade and stage as prognostic variables in upper tract urothelial tumors","volume":"62","author":"Huben","year":"1988","journal-title":"Cancer"},{"key":"10.1016\/j.juro.2009.05.011_bib8","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0022-5347(17)38059-X","article-title":"Tumors of the upper urinary tract: 10 years of experience","volume":"146","author":"Charbit","year":"1991","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2009.05.011_bib9","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1159\/000473758","article-title":"Prognostic factors of primary transitional cell carcinoma of the upper urinary tract","volume":"29","author":"Lee","year":"1996","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2009.05.011_bib10","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000282755","article-title":"Neoadjuvant chemotherapy for locally advanced urothelial cancer of the upper urinary tract","volume":"55","author":"Igawa","year":"1995","journal-title":"Urol Int"},{"key":"10.1016\/j.juro.2009.05.011_bib11","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.urology.2008.04.032","article-title":"Lymphovascular invasion and pathologic tumor stage are significant outcome predictors for patients with upper tract urothelial carcinoma","volume":"72","author":"Bolenz","year":"2008","journal-title":"Urology"},{"key":"10.1016\/j.juro.2009.05.011_bib12","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000092930","article-title":"Adjuvant chemotherapy in the management of pT3N0M0 transitional cell carcinoma of the upper urinary tract","volume":"77","author":"Lee","year":"2006","journal-title":"Urol Int"},{"key":"10.1016\/j.juro.2009.05.011_bib13","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.urology.2006.01.053","article-title":"Adjuvant systemic chemotherapy in the treatment of patients with invasive transitional cell carcinoma of the upper urinary tract","volume":"68","author":"Kwak","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.juro.2009.05.011_bib14","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1046\/j.1464-410X.1998.00746.x","article-title":"Adjuvant chemotherapy for high-risk urothelial transitional cell carcinoma: the Princess Margaret Hospital experience","volume":"82","author":"Michael","year":"1998","journal-title":"Br J Urol"},{"key":"10.1016\/j.juro.2009.05.011_bib15","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1200\/JCO.2004.09.043","article-title":"Adjuvant chemotherapy with paclitaxel and carboplatin in patients with advanced carcinoma of the upper urinary tract: a study by the Hellenic Cooperative Oncology Group","volume":"22","author":"Bamias","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.juro.2009.05.011_bib16","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S1470-2045(06)70803-8","article-title":"Chronic renal disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study","volume":"7","author":"Huang","year":"2006","journal-title":"Lancet Oncology"},{"key":"10.1016\/j.juro.2009.05.011_bib17","doi-asserted-by":"crossref","first-page":"5397","DOI":"10.1200\/JCO.2006.10.4521","article-title":"Phase II study of uracil-tegafur with leucovorin in elderly (> or = 75 years old) patients with colorectal cancer: ECOG 1299","volume":"25","author":"Hochster","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.juro.2009.05.011_bib18","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1200\/JCO.2005.04.9452","article-title":"Randomized phase II trial of paclitaxel plus carboplatin or gemcitabine plus cisplatin in Eastern Cooperative Oncology Group performance status 2 non-small-cell lung cancer patients: ECOG 1599","volume":"25","author":"Langer","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.juro.2009.05.011_bib19","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/cncr.11691","article-title":"The development of bladder tumors and contralateral upper urinary tract tumors after primary transitional cell carcinoma of the upper urinary tract","volume":"98","author":"Kang","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.juro.2009.05.011_bib20","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1002\/cncr.22970","article-title":"Independent predictors of cancer-specific survival in transitional cell carcinoma of the upper urinary tract: multi-institutional dataset from 3 European centers","volume":"110","author":"Novara","year":"2007","journal-title":"Cancer"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0022534709011513?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0022534709011513?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2009.05.011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T01:48:37Z","timestamp":1651196917000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2009.05.011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["10.1016\/j.juro.2009.05.011"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2009.05.011","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}